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Structure-reactivity relationships of L-proline derived spirolactams and -methyl prolinamide
organocatalysts in the asymmetric Michael addition reaction of aldehydes to nitroolefins.
Fintan Kelleher,* Sinead Kelly, John Watts and Vickie McKee
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Structure-reactivity relationships of L-proline derived spirolactams and methyl prolinamide organocatalysts in the asymmetric Michael addition reaction
of aldehydes to nitroolefins.
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Abstract:
L-Proline

derived spirolactams and -methyl prolinamides act as organocatalysts for

the asymmetric conjugate addition of aldehydes to nitroolefins in excellent yields,
with good diastereoselectivity and enantioselectivity. Furthermore, low catalyst
loadings (5 mol%) and a low aldehyde molar excess (1.5 molar equivalents) were
achieved.

Keywords
Spirolactam; -methyl prolinamide; Asymmetric Organocatalysis; Michael addition
reaction.

Introduction
The field of organocatalysis has seen an explosion of interest in the last decade.1 In
particular, L-proline derived compounds have found use as organocatalysts in the
asymmetric Michael addition reaction of aldehydes and ketones to nitroolefins, with
the products being produced in high yields, with excellent diastereo- and
enantioselectivities (Figure 1).1-6 However, in many earlier cases either a large excess
of the aldehyde or ketone is required (10-20 molar equivalents) or high levels of
catalysts (10-25 mol%). More recently highly efficient catalyst systems for this
transformation have been developed and are the benchmark for all new catalysts. Ma
2

was able to achieve high yields and selectivities using only 0.5 mol% of 4 and 1.5
equivalents of aldehyde in the presence of benzoic acid as an additive.3 However,
Lombardo recently reported the use of the ion-tagged diphenylprolinol silyl ether 7
which achieves enantiomeric excesses of >99.5% at low catalyst loadings (0.25-5
mol%), and uses only a slight excess of aldehydes (1.2-2 molar equivalents).4 The
most efficient catalyst reported to-date is the tripeptide 8 described by Wennemers.5
This catalyst is highly efficient at levels of only 0.1-0.2 mol%, even with the
nitroalkene in excess, giving high yields and selectivities for a range of aldehydes and
nitroalkenes. The usefulness of the products from these reactions resides in the
potential for further transformation of both the nitro and carbonyl functionalities.
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Figure 1. Proline and 4-hydroxyproline derived organocatalysts.1-6

There is an ongoing requirement for the development of new organocatalysts for this
and other important chemical transformations, in order to fully understand the
structure-reactivity relationships of these catalysts. Many of the reported prolinederived catalysts are conformationally flexible in nature and it was thought that the
introduction of conformational constraints into the structure could lead to more
specific catalysts, which might allow the use of lower amounts of aldehyde or ketone,
along with the requirement for low levels of the organocatalyst (e.g. 5% or less). One
way to introduce such conformational constraint would be to have, for example, the L3

proline as part of a rigid spiro fused ring system. Royer recently prepared such a rigid
pyrrolidino spiro diamine (9, Figure 1) and it exhibited limited success in its ability to
act as an asymmetric organocatalyst in the Michael addition reaction of aldehydes to
nitroolefins, although only one set of reaction conditions was reported.6 Rather than
having the second amino group as an exocyclic substituent, incorporation of the
second nitrogen atom as part of the ring would give spirolactam and spirodiamine
structures.

Results and Discussion

As part of a program to synthesise both enantiomerically pure and racemic prolinederived [4.4]-spirolactams, we recently reported our studies on their preparation by
thermal intramolecular ester aminolysis methods.7 Diastereoisomeric spirolactams
(11a and 11b) were prepared and separated chromatographically (Figure 2).
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Figure 2. Synthesised spirolactam and spirodiamine organocatalysts
It was also found that the spiro diamine derivatives 13a and 13b complexed a zinc
ion.7c Although the stereochemistry of the -methyl benzyl substituent was known,
from the choice of the starting amine, the absolute stereochemistry of the spiro centre
in each of the diastereoisomers was not known. Previously, we were unable to grow
crystals of sufficient quality for X-ray analysis to be obtained, so NMR spectroscopy
4

along with molecular modelling7c was used to tentatively assign the stereochemistry
of the SR and RR diastereoisomeric pair, 11a and 11b. Eventually crystals of
sufficient quality were obtained of 11b, by crystallisation from hexane, and an X-ray
crystal structure was obtained (Figure 3), which confirmed the previous NMR
spectroscopic and modelling assignments.7b,c

Figure 3. Perspective view of 11b showing 50% probability ellipsoids. Hydrogen
atoms omitted for clarity.

The X-ray crystal structure clearly shows the R absolute stereochemistry at the spiro
centre. As a result of this structure, the absolute stereochemistry of both
diastereoisomers was now known. Treatment of 11a and 11b with trifluoroacetic acid
gave the desired deprotected compounds 12a and 12b. An examination of the
structures of these compounds shows that they can be considered as conformationally
constrained analogues of prolinamides, an important class of organocatalysts.
Therefore the investigation of the use of spirolactams 12a and 12b as organocatalysts
in the model reaction of valeraldehyde with trans--nitrostyrene was undertaken
(Table 1).
Table 1. Michael addition reaction of valeraldehyde to -nitrostyrene.
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O

Ph

+

H

NO2

n-Pr

Entry Solvent Cat
1
2
3
4
5
6
7
8
9
10
11
12
13
14

DCM
CHCl3
i-PrOH
THF
DMSO
DCM
DCM
DCM
DCM
CHCl3
i-PrOH
DCM
DCM
DCM

12a
12a
12a
12a
12a
12a
12a
12a
12b
12b
12b
12b
15a
15b

Add
TFA
-

O

Catalyst

n-Pr

Loading Aldehyde
(mol%) (mol eq.)
5
5
5
5
5
5
5
20
5
5
5
5
5
5

NO2

H

72 h

1.5
1.5
1.5
1.5
1.5
1.5
10
10
1.5
1.5
1.5
1.5
1.5
1.5

Ph

16

Temp.

Yielda

drb

eec

RT
RT
RT
RT
RT
4
RT
RT
RT
RT
RT
RT
RT
RT

98
98
98
43
80
77
90
98
98
96
72
71
98
98

62:38
65:35
67:33
74:26
74:26
70:30
73:27
64:36
67:33
65:35
68:32
60:40
62:38
71:29

66
65
45
80
25
76
80
72
63d
68d
63d
53d
32
56d

a

Isolated yield after chromatography
Syn:anti ratio determined by 1H NMR spectroscopy
c
e.e. of syn isomer determined by chiral HPLC
d
Opposite enantiomer of the syn product
b

The first reaction was conducted using a low molar excess of valeraldehyde (1.5
equivalents) in dichloromethane at room temperature for 72 h in the presence of 5
mol% of (S,R)-spirolactam 12a (entry 1). Product 16 was isolated in 98% yield, with a
syn:anti ratio of 62:38, and the enantiomeric excess (e.e.) of the syn isomer was 66%.
Changing the solvent to chloroform or 2-propanol gave similar results, while the use
of THF as solvent gave a better syn:anti ratio of 74:26 and an e.e. of 80% for the syn
isomer, although the isolated yield was much reduced at 43% (entries 2, 3 and 4).
DMSO gave an 80% yield, with a syn:anti ratio of 74:26, but a poor e.e. of only 25%
(entry 5). For further studies, DCM was used as solvent. The effect of temperature on
the outcome of the reaction was examined by running the reaction at 4 oC (entry 6). In
this case, the isolated yield was reduced to 77%, while the syn:anti ratio improved to
70:30, with the syn isomer having an improved e.e. of 76%, when compared to the
reaction at room temperature. Increasing the amount of valeraldehyde to 10 molar
equivalents surprisingly gave a slight reduction in isolated yield to 90%, when
compared to the use of 1.5 molar equivalents (98%, entry 1), but with an improved
syn:anti ratio of 73:27, and an e.e. of 80% for the syn isomer (entry 7). Repeating this
6

reaction with 20 mol% of the catalyst, brought the isolated yield back to 98%, but
unfortunately, the syn:anti ratio reduced to 64:36, with a concomitant reduction in the
e.e. of the syn isomer to 72% (entry 8).

Use of the diastereoisomeric (R,R)-spirolactam 12b as catalyst, under the standard
conditions, gave similar isolated yields to those obtained with 12a, with similar
syn:anti ratios (Entries 9, 10 and 11). The enantiomeric excesses were also similar
but, most importantly, in these cases the opposite enantiomer of the syn
diastereoisomer now predominated, as shown by chiral HPLC analysis. Other groups
have observed an improvement in both the diastereoisomeric ratio and the e.e. of the
syn isomer on the addition of acidic additives, such as trifluoroacetic acid (TFA).
Addition of 1 molar equivalent of TFA, using spirolactam 12b as catalyst, gave a
reduced isolated yield, with poorer diastereocontrol (Entry 12). All of these results
show that it is the absolute stereochemistry of the spiro centre which is controlling the
observed enantioselectivity, with the stereochemistry of the side-chain substituent
having little effect. This is not surprising if the proposed transition state models of the
reactions are considered (Figure 4).
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Figure 4. Proposed transition state model for Michael addition reaction of
valeraldehyde with -nitrostyrene using spirolactam catalysts.
The syn diastereoselectivity observed is due to the “Seebach acyclic synclinal
model”,8 in which there are favourable electrostatic interactions in the transition state
between the enamine nitrogen and the nitro group. For the syn diastereoisomeric pair
the Re face of the nitrostyrene can approach the enamine Re face in two different
8

ways (Re,Re-1 and Re,Re-2, Figure 4), depending on whether it approaches from the
same, or opposite, side as the lactam carbonyl group. Similarly the Si face of the nitro
styrene can approach enamine Si face in two ways (Si,Si-1 and Si,Si-2). Of the two
possible Re,Re trajectories Re,Re-2 is the much more likely because there are two
destabilising steric interactions present in the Re,Re-1 trajectory, namely the less
favourable enamine rotamer as well as the interaction of the nitrostyrene with the
lactam carbonyl group. Neither of these interactions are present in the Re,Re-1
trajectory. Of the two possible Si,Si trajectories Si,Si-1 has the favourable enamine
rotamer but a steric interaction with the lactam carbonyl, while Si,Si-2 has a steric
interaction with the methylene of the lactam ring, as well as being the less favoured
enamine rotamer. It is therefore not apparent which of these trajectories is more
favoured. Overall, it is thus the contribution of favourable electrostatic interactions as
well as the unfavourable steric interactions which controls the observed
diastereoselecetivity and enantioselectivity. In the case of the use of the spirolactam
12b as catalyst, with the opposite stereochemistry at the spirocentre, the transition
state with the Si,Si approach of the faces of the -nitrostyrene and the enamine would
be the predominant pathway, thus giving the observed (R,S) enantiomer as the major
product.

Increasing the steric bulk of the spirolactam side-chain was achieved by replacing the
phenyl group with the 1-naphthyl group. The spirolactams were synthesised in an
analogous manner to the phenyl substituted compounds,7c but (R)-(1)-(1naphthyl)ethylamine was used in place of (R)-(1)-phenylethylamine. As before the
two diastereoisomeric spirolactams, 14a and 14b, were separable. Their
stereochemistries were tentatively assigned by comparison of their NMR spectral data
(chemical shifts and coupling constants) with the phenyl-derived compounds, as well
as their relative polarities as measured by TLC analysis. Use of the Boc deprotected
compounds 15a or 15b in the Michael addition reaction gave similar yields and
diastereoselectivities to those of the corresponding phenyl derivatives 12a and 12b,
but with slightly lower enantioselectivities (Table 1, entries 13 and 14). This confirms
that the lactam side-chain is having little effect on the stereochemical outcome of the
reaction.

9

The scope of the catalysts (12a and 12b) was examined by reacting different
aldehydes and -nitrostyrenes under the optimised conditions (Table 2).
Propionaldehyde showed poor diastereo- and enantioselectivity (d.r. 62:38, e.e. 34%)
and a reduced isolated yield of 77% (entry 1), while the more hindered isovaleraldehyde showed excellent diastereocontrol (d.r. 89:11) and a hugely improved
e.e. of 82% (entry 2). Unfortunately, the isolated yield was poor (22%) due to the
increased steric effect of the branched aldehyde. Reaction of valeraldehyde with
substituted -nitrostyrenes show similar diastereo- and enatioselectivity to the parent

-nitrostyrene (entries 3-8). The reason for the very poor enantioselectivity of catalyst
12b (4% e.e.) with the para-methoxy substituted -nitrostyrene (entry 6) is not
known.
Table 2. Michael addition reaction of aldehydes to -nitrostyrenes
O

Ar

+

H

NO2

R1

Entry Cat
1
2
3
4
5
6
7
8

12b
12b
12a
12b
12a
12b
12a
12b

O

Catalyst (5 %)

Ar
NO2

H

DCM, RT, 72 h

R1

R1

Ar

Yielda

drb

eec

Me
i-Pr
n-Pr
n-Pr
n-Pr
n-Pr
n-Pr
n-Pr

Ph
Ph
p-tolyl
p-tolyl
p-MeOC6H4
p-MeOC6H4
p-ClC6H4
p-ClC6H4

77
22
94
90
86
82
90
92

62:38
89:11
60:40
63:37
56:44
57:43
55:45
62:38

34
82
54
62d
78
4d
51
73d

Reactions carried out with 1.5 molar equivalents of aldehyde.
a

Isolated yield after chromatography
Syn:anti ratio determined by 1H NMR spectroscopy
c
e.e. of syn isomer determined by chiral HPLC
d
Opposite enantiomer of the syn product
b

Many of the reported catalysts used to catalyse the Michael addition reaction of
aldehydes and ketones to nitroolefins have been diamines derived from L-proline
(Figure 1).1,2,6 For comparison, spirodiamines 13a and 13b were prepared, from
spirolactams 12a and 12b, by removing the Boc group and reducing the lactam ring to
the cyclic amine with lithium aluminium hydride.7c When 13a was used as a catalyst
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in the Michael addition reaction similar syn:anti ratios were obtained, to those when
the corresponding spirolactams were used, though the isolated yield was only 85%
(Table 3, entry 1).
Table 3. Michael addition reaction of valeraldehyde to -nitrostyrene catalysed by
diamines 13a and 13b.
O

Ph

+

H

O

Catalyst

NO2

H

NO2

n-Pr

Ph

n-Pr

Entry Cat Additive Loading Aldehyde Yielda
(mol%) (mol eq.)
1
2
3
4
5
6

13a
13b
13a
13a
13a
13b

TFA
HCl
TFA

5
5
20
5
5
5

1.5
1.5
10
1.5
1.5
1.5

85
85
98
99
99
98

drb

eec

65:35 2
68:32 14d
67:33 2
61:39 3
62:38 0
65:35 3d

Reactions carried out in DCM at ambient temperature, for 72 hours.
a

Isolated yield after chromatography
Syn:anti ratio determined by 1H NMR spectroscopy
c
e.e. of syn isomer determined by chiral HPLC
d
Opposite enantiomer of the syn product
b

In these cases, however, the enantioselectivity was severely reduced, with the syn
isomer now being obtained in close to racemic form. Increasing the amount of catalyst
to 20 mol% only increased the isolated yield back to 98%, with no effect on the
stereoselectivity of the reaction (entry 3). The addition of TFA or HCl as an additive,
or using the epimeric spiro diamine 13b, had no effect on this outcome (entries 2, 4, 5
and 6). The selectivity of substituted pyrrolidine-based organocatalysts in the Michael
addition reaction is mostly determined by the nature of the substitutent in the 2position (trans-4-hydroxy substitutents also exert control).1j For substituents with a
hydrogen bond donor present (e.g. COOH in L-proline or the N-H in prolinamides and
sulfonamides), it is the attractive interaction with the nitro group of the styrene and
the hydrogen bond donor which controls the facial selectivity.1a,1j In the absence of
such hydrogen bond donors the facial selectivity is controlled by the steric effect of
11

the pyrrolidine side-chain. In this study, there is no hydrogen bond donor present in
the spirolactams and thus the facial selectivity is as described previously. The results
with the diamines 13a and 13b can be explained by examining the transition state
model of the reaction (Figure 4). In the absence of the lactam carbonyl group the
Re,Re-2 and Si,Si-1 trajectories are equally likely, since there is now a methylene
attached to both sides of the quaternary spiro carbon. This leads to equal steric
preference for the Re,Re-2 and Si,Si-1 trajectories and thus racemic products are
obtained. In this case although the spiro diamine is more conformationally flexible,
the bulky nitrogen side-chain is too remote from the spiro centre to have any impact
on the stereocontrol.

It would be envisaged that either breaking the lactam ring to give more
conformational flexibility (17) or removal of the spiro fusion completely, to give
simple prolinamides 18, might lead to improvements in the observed stereocontrol
(Figure 5).
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Figure 5. Conformationally flexible spirolactam analogues.
For direct comparison with the spirolactam studies it was decided to keep the methyl benzylamine sidechains. The synthesis of the two sets of four stereoisomers of
17 (R = Me or H) started from N-Boc-L-proline methyl ester 19 (Scheme 1).
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Scheme 1: Reagents and conditions; (a) i) LiHMDS, THF, -78 oC, ii) methyl iodide, rt, 72%;
(b) i) NaOH, MeOH/H2O, reflux, ii) 1M HCl, 93%; (c) (R)-N,-dimethylbenzyl amine, DIPEA,
HATU, DMF, rt, 49%; (d) 50% TFA in DCM, rt, 88-92%; (e) (R)--methylbenzyl amine, DIPEA,
HATU, DMF, rt, 94%; (f) 50% TFA in DCM, rt, 93-96%.

-Methylation of 19 with methyl iodide gave the racemic -methyl ester 20 in 72%
yield, which was hydrolysed to the -methyl carboxylic acid 21, in 93% yield. The
racemic acid was then coupled, separately with R- or S-N,-dimethylbenzylamine,
using HATU as the coupling agent, to give the four N-methylated diastereoisomeric

-methyl prolinamides (22a-d). 21 was also coupled, separately, with R- or S-methylbenzylamine, under similar conditions, to give the four N-H stereoisomeric methyl prolinamides (22e-h). Removal of the Boc group in each of the eight
compounds gave the free amines 17a-h. The relative stereochemistry of each
compound was obtained from X-ray crystal structure data. Only one compound from
each set gave crystals suitable for X-ray analysis (Figure 6).
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17b (R,R)

22g (R,S)

Figure 6. X-ray structures of the cation of 17b and one of the two independent
conformations of 22g. Both structures are drawn with 50% probability ellipsoids.
Tosyl anion in 17b has been omitted for clarity.
Since the stereochemistry of the amine side-chain was known, from the choice of
amine starting material, the absolute stereochemistry of the quaternary centre was
easily obtained. The crystalline side-chain N-H compound was obtained as its Boc
derivative 22g (R,S stereochemistry) while the side-chain N-Me compound was
obtained as its ammonium tosylate salt (17b.TsOH, R,R stereochemistry).
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The simple L-prolinamides 18 were prepared from L-proline by Boc protection of the
proline nitrogen, to give N-Boc-L-proline 23, in almost quantitative yield, followed
by separately coupling to R- or S--methylbenzylamine, to give the two
diastereoisomeric prolinamides 24a and 24b (Scheme 2, only reaction with (R)-methylbenzylamine to give 24a is shown).
Me
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N
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N
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N

N
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a

18c

c
b

N
Boc

Me

d

COOH
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N
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N
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Scheme 2: Reagents and conditions; (a) i) NaOH, MeOH/H2O, reflux, ii) 1M HCl, 98%;
(b) (R)--methylbenzyl amine, DMAP, EDC, DCM, rt, 90%; (c) i) LiHMDS, THF, -78 oC,
ii) methyl iodide, rt, 92%; (d) 50% TFA in DCM, rt, 86-91%.

In these cases, efficient coupling was achieved using EDC, whereas HATU was
necessary in the more sterically hindered coupling reactions above. N-methylation of
24a (or 24b), with methyl iodide, gave the N-methyl prolinamide 25a (or 25b).
Deprotection of 24a and 24b gave the N-H L-prolinamides 18a and 18b (R = H),
while deprotection of 25a and 25b gave the N-Me L-prolinamides 18c and 18d (R =
Me). Prolinamides 18a and 18b are known and have previously been described by
Chimni as efficient organocatalysts, as their HBr salts, for the direct aldol reaction in
water.9 Earlier Wu and Gong also described their use as enantioselective catalysts for
direct aldol reactions.10
The -methyl prolinamides 17a, 17b, 17e and 17f and simple prolinamides 18a-d
were then examined as organocatalysts in the standard reaction (Table 4).

Table 4. Michael addition reaction of valeraldehyde to -nitrostyrene catalysed by
17a, 17b, 17e, 17f and 18a-d.
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O

Ph

+

H
n-Pr

O

Catalyst

Ph
NO2

H

NO2

n-Pr

Entry

Catalyst

Yielda

drb

eec

1
2
3
4
5
6
7
8

17a (S,R)
17b (R,R)
17e (S,R)
17f (R,R)
18a (S,R)
18b (S,S)
18c (S,R)
18d (S,S)

98
98
55
60
98
98
98
94

61:39
62:38
56:44
56:44
77:23
98:2
93:7
94:6

40
59d
63
59 d
71
81
49
65

Reactions carried out in DCM with 1.5 molar equivalents of aldehyde, at ambient
temperature, for 48 hours.
a

Isolated yield after chromatography
Syn:anti ratio determined by 1H NMR spectroscopy
c
e.e. of syn isomer determined by chiral HPLC
d
Opposite enantiomer of the syn product
b

The N-methyl--methyl compounds 17a and 17b gave very similar overall results to
those obtained for the corresponding spirolactams 12a and 12b, with similar
diastereocontrol but a slight decrease in enantioselectivity (entries 1 and 2). It is very
important to note that the major syn enantiomer (16 (R,S)) obtained for 17a is
opposite to that obtained with the spirolactam 12a (Figure 2). The -methyl N-H
compounds 17e and 17f showed similar stereoselectivity, but surprisingly much
reduced isolated yields of 55% and 60%. The reason for these reduced yields is not
known, at present. These results clearly demonstrate that the presence of a proline substitutent is detrimental to achieving high levels of stereocontrol. This was borne
out when the -hydrogen N-Me catalysts 18c and 18d were examined. With the
removal of the -methyl substituent the isolated yield was brought back to 94-98%
with excellent diastereoselectivity (~94:6). Unfortunately, there was no observed
increase in enantioselectivity (entries 7 and 8). Finally, the two N-H catalysts 18a and
18b were examined and found to give excellent isolated yields, diastereoselectivity
and hugely improved enantioselectivity (71 and 81% e.e.). The diastereoselectivity for
these two catalysts are quite different (77:23 and 98:2) and since both contain an N-H
in the side-chain this difference is likely to be due to the overall conformation of the
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side-chain

(entries

5

and

6).

Although

18b

gave

excellent

yield

and

diastereoselectivity results, the enantiomeric excess was 81%, which is below the
levels reported for many proline-derived catalysts.3-5 For this reason studies on the
expansion of the scope of these catalysts in the Michael addition reaction with
different aldehydes and substituted -nitrostyrenes were not undertaken. The
proposed transition state model, involves a steric interaction between the nitro styrene
and the amide side-chain on position 2 of the pyrrolidine which destabilises the Re,Re
approach for these catalysts (Figure 7), even though there is a favourable electrostatic
interaction between the nitro group and the enamine nitrogen. Thus the Si,Si approach
predominates where there is a favourable electrostatic interaction between the nitro
group and the enamine nitrogen, but no steric interaction with the amide side-chain,
thus giving the R,S enantiomer of 16 as the major enantiomer. The selectivity
observed is regardless of whether the side-chain contains an N-H, as a potential
hydrogen bond donor for a favourable electrostatic interaction with the nitro group, or
whether it is N-methylated.
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Figure 7. Proposed transition state model for Michael addition reaction of
valeraldehyde with -nitrostyrene using simple prolinamide catalysts 18a-d.
From these studies, it is therefore apparent that the absence of an -substituent and
the presence of a sufficiently bulky prolinamide are necessary for the optimal simple
prolinamide organocatalyst, for the Michael addition reaction of aldehydes to nitrostyrenes.

Conclusions
In conclusion, the main advantage of the spirolactam and -methyl prolinamide
organocatalysts used in this study is that both epimers of the -centre can be easily
synthesised from a common starting material,

L-proline.

It is thus possible to

selectively form either enantiomer of the syn Michael addition product, in excellent
yield with good stereocontrol. In the case of other proline-derived catalysts, this
would only be possible by separately preparing catalysts starting with

D-proline.

Furthermore, the amount of catalyst required for activity is low (5 mol%), along with
the requirement of only 1.5 molar equivalents of the aldehyde partner. As stated
previously the presence of a trans-4-hydroxy substitutent can have a considerable
effect on the stereoselectivity obtained and we are also currently preparing analogues
of all the synthesised organocatalysts reported here with this functionality present.
Further studies on the scope of use of these new organocatalysts in the Michael
addition reaction and other important asymmetric transformations are being
undertaken, the results of which will be reported in due course.

Experimental.

TLC was performed on Merck silica gel 60F254 plates and column chromatography
was performed on Aldrich silica gel, 70-230 mesh, 60Å. 1H and 13C NMR ( ppm; J
Hz) spectra were recorded on a Jeol JNM-LA300 FT-NMR spectrometer using CDCl3
solutions with Me4Si as internal reference, unless otherwise indicated, with
resolutions of 0.18 Hz and 0.01 ppm, respectively. CHCl3 was used to remove last
traces of ethyl acetate from some samples. The last trace of CHCl3 persisted even
18

after prolonged heating in vacuo and in these cases was visible in NMR spectra.
Infrared spectra (cm-1) were recorded as KBr discs or liquid films between NaCl
plates using a Nicolet Impact 410 FT-IR. Melting points were obtained on a Bibby
Stuart Scientific SMP1 melting point apparatus. Microanalyses were carried out at the
Microanalytical Laboratory of University College Dublin. High Resolution Mass
spectra were obtained in the Centre for Synthesis and Chemical Biology, School of
Chemistry and Chemical Biology, University College Dublin. X-ray crystal structures
were

obtained

in

the

Chemistry

Department,

Loughborough

University,

Loughborough, UK. Chiral HPLC analysis were carried out using on a Shimadzu
HPLC system Class-VP, incorporating a LC-10AD pump, SPD-M10AVP Diode
Array Detector, Auto-injector SIJ-10A with a system controller SCL-10A VP, on
Chiralcel OD-H and AD-H chiral columns. Polarimetry was carried out using an
Optical Activity AA-55 series polarimeter at ambient temperature with a 2 dm, 1 ml
cell. ()-2-Methyl-pyrrolidine-1,2-dicarboxylic acid 1-tert-butyl ester (20) is
commercially available but was synthesised (vide infra).
N-Boc-L-proline methyl ester (19).11
19 was prepared from L-proline by the method of Confalone11 giving 19 as a clear oil.
Analytical data was in agreement with that reported. Microanalysis: Found C, 57.51;
H, 8.60; N, 5.88. Calculated for C11H19NO4: C, 57.60; H, 8.34; N, 6.10.
()--Formylmethyl N-Boc-proline methyl ester was prepared from 19 as
previously described.7c

(5S)

and

(5R)-6-Oxo-7-((1’R)-naphthylethyl-)-1,7-diaza-spiro[4.4]nonane-1-

carboxylic acid tert-butyl ester (14a and 14b).
Prepared from ()--formylmethyl N-Boc-proline methyl ester 19 (0.65 g, 2.4 mmol)
and (R)-1-(1-naphthyl)ethylamine (0.35ml, 2.50mmol), using the method as
previously described for 12a and 12b,7c giving a yellow oil (0.75g, 79%). The oil was
purified on silica gel using 20% ethyl acetate/petroleum ether giving the two
diastereoisomers.
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(S,R) Diastereoisomer (14a): Yellow solid, (0.33g, 35%). Rf:

0.50 (60% ethyl

acetate: petroleum ether). [α]D: +46.66 (c = 0.75 in MeOH). M.p.: 153-155 oC. IR,
(KBr)/cm-1: 3031, 2984, 1685, 1676. 1H NMR (two rotamers present) δ: 8.00, 7.81,
7.50, (3 x m, 7H), 6.13 (q, 1H, J = 7.2 Hz), 3.62-3.45 (m, 3H), 3.27 & 3.08 (2 x t, 1H,
J = 9.0 Hz), 2.55-2.30 (m, 2H), 2.15-2.05 (m, 2H), 1.98-1.91 (m, 2H), 1.74 (t, 3H, J =
7.3 Hz), 1.51 & 1.48 (2 x s, 9H). 13C NMR (two rotamers present) δ: 173.2, 153.6 &
153.4, 137.4, 135.6, 133.7, 128.7, 128.5, 126.0, 124.8, 124.1, 123.8, 123.7, 80.2 &
79.4, 67.6 & 67.5, 48.1 & 48.0, 46.0 & 46.2, 38.8 & 38.3, 36.8 & 36.6, 30.1 & 29.8,
24.7, 23.3 & 23.1, 16.2 & 15.8. HRMS (ESI) calculated for C24H31N2O3 [M+H]+:
395.2335. Found: 395.2336.

(R,R) Diastereoisomer (14b): Yellow oil, (0.36g, 38%). Rf: 0.40 (60% ethyl acetate:
petroleum ether). [α]D: +40.5 (c = 1 in MeOH). IR, (Thin film)/cm-1: 3031, 2986,
1680, 1676. 1H NMR (two rotamers present) δ: 8.61(d, 1H, J = 8.2 Hz), 8.20 (d, 1H,
J = 8.3 Hz), 7.81 & 7.50, (2 x m, 6H,), 6.27 (q, 0.5H, J = 6.8 Hz), 6.06 (q, 0.5H, J =
6.8 Hz), 3.69-3.42 (m, 2H), 3.28 (m, 1H), 3.12-2.90 (m, 1H), 2.69 (t, 1H, J = 7.0 Hz),
2.41-1.67 (m, 5H), 1.63 (d, 3H, J = 7.0 Hz), 1.45 (s, 9H).
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C NMR (two rotamers

present) δ: 173.5, 153.6, 136.5, 135.8, 133.2, 128.6, 128.2, 126.1, 125.0, 124.4,
123.9, 123.8, 79.8 & 79.4, 68.0 & 67.8, 48.3 & 48.1, 46.5 & 46.2, 38.7 & 38.5, 37.1
& 36.8, 29.9 & 29.8, 28.6, 22.6 & 22.2, 16.4 & 16.1. HRMS (ESI) calculated for
C24H31N2O3 [M+H]+: 395.2335. Found: 395.2328.

(5S)-6-Oxo-7-((1’R)-naphthylethyl-)-1,7-diaza-spiro[4.4]nonane (15a)
To a solution of 14a (0.145 g, 0.42 mmol) in DCM (0.3 ml) was added TFA (0.3 ml,
1.28 mmol), and then stirred at ambient temperature for 16 hr. The solution was then
concentrated in vacuo, dissolved in H2O (40 ml), and the pH adjusted to ~ 8 by adding
Et3N dropwise, at 0 oC. The product was then extracted with DCM (3 x 20 ml), dried
over MgSO4, and concentrated in vacuo yielding an oil, which was purified on silica
gel using 5% MeOH:DCM, giving the product.

(S,R) Diastereoisomer (15a): yellow oil (0.77g, 90%). Rf: 0.5 (10% MeOH: DCM).
[α]D: +8.2 (c = 1.1 in MeOH). IR, (Thin film)/cm-1: 3332, 3032, 2995, 1684. 1H
NMR δ: 7.99-7.96 (m, 1H), 7.88-7.81 (m, 2H), 7.56-7.44 (m, 4H), 6.10 (q, 1H, J =
7.0 Hz), 3.27-3.22 (m, 1H), 3.12-3.05 (m, 1H), 2.98-2.90 (m, 1H), 2.28-2.22 (m, 1H),
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1.71-1.93 (m, 7H), 1.68 (d, 3H, J = 7.1 Hz). 13C NMR δ: 176.0, 135.1, 133.7, 131.6,
128.7, 128.6, 128.3, 126.8, 124.9, 124.1, 123.4, 68.1, 47.5, 46.1, 39.1, 35.3, 34.8,
26.0, 16.1. HRMS (ESI) calculated for C19H23N2O [M+H]+: 295.1810. Found:
295.1801.
(5R)-6-Oxo-7-((1’R)-naphthylethyl-)-1,7-diaza-spiro[4.4]nonane (15b)
Was prepared from 14b in a similar manner to the preparation of 15a.

(R,R) Diastereoisomer (15b): yellow oil (0.78g, 92%). Rf: 0.3 (10% MeOH: DCM),
[α]D: +11.0 (c = 1 in MeOH). IR, (Thin film)/cm-1: 3335, 3030, 2994, 1685. 1H
NMR δ: 8.10-8.01 (m, 0.5H), 7.87-7.81 (m, 0.5H), 7.55-7.48 (m, 2H), 7.46-7.21 (m,
4H), 6.14 (q, 1H, J = 7.0 Hz), 3.28-3.22 (m, 1H), 3.18-3.05 (m, 1H), 2.98-2.91 (m,
1H), 2.56-2.45 (m, 1H), 2.14 -1.68 (m, 7H), 1.60 (d, 3H, J = 7.1 Hz).
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C NMR δ:

176.1, 135.1, 133.8, 131.5, 128.8, 128.6, 128.4, 126.8, 125.0, 124.2, 123.6, 68.4, 47.3,
46.2, 39.1, 35.2, 34.3, 25.8, 16.3. HRMS (ESI) calculated for C19H23N2O [M+H]+:
295.1810. Found: 295.1802.

()-2-Methyl-pyrrolidine-1,2-dicarboxylic acid 1-tert-butyl ester 2-methyl ester
(20)
To a solution of 19 (0.5 g, 2.18 mmol) in dry THF (2 ml) at -20 oC, was added a 1.0M
solution of LiHMDS in THF (3.1 ml, 3.1 mmol) slowly while keeping the temperature
below -15 oC. The solution was stirred for 1.5 hr, under nitrogen, at this temperature.
Methyl iodide (0.25 ml, 3.1 mmol) was added slowly at -20 oC. The solution was
stirred while allowing it to warm to ambient temperature. After 18 hr the solution was
quenched with a saturated aqueous solution of NH4Cl (5 ml), extracted with ethyl
acetate (3 x 20 ml), washed with a brine solution (3 x 10 ml) and then dried over
MgSO4. The resulting solution was concentrated in vacuo and was purified by column
chromatography on silica gel, using 10 % ethyl acetate: petroleum ether, giving a
colourless oil (0.38 g, 72 %). Rf: 0.50 (20 % ethyl acetate: petroleum ether). IR, (Thin
film)/cm-1: 2975, 1750, 1692, 1418. 1H NMR (two rotamers present) δ: 3.75 (s, 3H),
3.70-3.64 (m, 1H), 3.62-3.43 (m, 1H), 2.23-2.05 (m, 1H), 2.04-1.92 (m, 3H), 1.58 (s,
3H), 1.45 & 1.41 (2 x s, 9H). 13C NMR (two rotamers present) δ: 175.4, 153.6, 79.9,
64.8, 52.1, 47.9, 40.1, 28.2, 23.1, 22.3.
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()-2-Methyl-pyrrolidine-1,2-dicarboxylic acid 1-tert-butyl ester (21)
A suspension of 20 (1.25 g, 5.14 mmol) and NaOH (0.204 g, 5.1 mmol) in
MeOH/H2O (1:1, 20 ml) was heated at reflux temperature for 5 hr. The solvent was
removed in vacuo, and the residue was partitioned between diethyl ether and H2O
(1:1, 20 ml). The aqueous phase was then washed with diethyl ether (3 x 10 ml),
acidified to pH 3 using 1N HCl, followed by extraction with diethyl ether. The ether
layer was then dried over MgSO4 and concentrated in vacuo yielding the product
(1.10 g, 93 %), which was used without further purification. Rf: 0.10 (20 % ethyl
acetate: petroleum ether). M.p.: 91-94 oC. IR, (Thin film)/cm-1: 2978, 1740, 1648,
1432. 1H NMR (two rotamers present) δ: 3.62-3.42 (m, 2H), 2.60 (m, 1H), 2.45 &
2.28 (2 x m, 1H), 1.95-1.77 (m, 2H), 1.62 (s, 3H), 1.48 & 1.42 (2 x s, 9H). 13C NMR
(two rotamers present) δ: 176.5, 152.3, 80.6, 66.8, 48.7, 38.4, 28.4, 22.8, 22.2.

2-Methyl-2-[methyl-(1-phenylethyl)-carbamoyl]-pyrrolidine-1-carboxylic

acid

tert-butyl ester (22a and 22b).
To a stirred solution of 21 (0.45 g, 1.96 mmol) in dry DMF (9 ml) was added DIPEA
(0.675 ml, 3.92 mmol), followed by (R)-N-methyl--methylbenzyl amine (0.25 ml,
1.96 mmol) dropwise. After stirring for 5 min. the solution was cooled to 0 oC, and a
solution of HATU (0.752 g, 1.98 mmol) in dry DMF (9 ml) was added slowly. After
10 min at this temperature, the solution was allowed to warm to ambient temperature
and stirring was continued for 4 hr. The solution was diluted with EtOAc (200 ml),
and then washed successively with 10 % HCl solution (3 x 10 ml), saturated aqueous
sodium carbonate solution (3 x 10 ml), H2O (3 x 10 ml) and brine solution (3 x 10
ml), and then dried over MgSO4. The solution was concentrated in vacuo giving the
crude product (0.65 g) which was purified by column chromatography on silica gel in
10 % ethyl acetate: petroleum ether.

(S,R) Diastereoisomer (22a): Colourless oil, (0.12 g, 18 %). Rf: 0.7 (40 % ethyl
acetate: petroleum ether). [α]D: +8.18 (c = 0.55 in MeOH). IR, (Thin film)/cm-1:
2976, 1686, 1678. 1H NMR (two rotamers present) δ: 7.36-7.24 (m, 5H), 6.18-6.11
(m, 1H), 3.75-3.63 & 3.60-3.52 (2 x m, 1H), 3.38-3.30 (m, 1H), 2.61 & 2.56 (2 x s,
3H), 2.16-1.96 (m, 4H), 1.59 (s, 3H), 1.56 & 1.52 (2 x s, 3H), 1.48 (s, 9H). 13C NMR
(two rotamers present) δ: 173.0, 153.5, 141.3, 128.5, 127.1 & 126.8, 80.3, 66.2, 51.7,
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46.7, 38.1, 29.7, 28.3, 24.7, 23.8, 22.1. HRMS (ESI) calculated for C19H29N2O3
[M+H]+: 347.2335. Found: 347.2318.

(R,R) Diastereoisomer (22b): Colourless oil, (0.21 g, 31 %). Rf: 0.6 (40 % ethyl
acetate: petroleum ether). [α]D: +23.9 (c = 0.67 in MeOH). IR, (Thin film)/cm-1:
2972, 1680, 1678. 1H NMR (two rotamers present) δ: 7.40-7.26 (m, 5H), 6.21-6.09
(m, 1H), 3.78-3.62 & 3.59-3.51 (2 x m, 1H), 3.36-3.23 (m, 1H), 2.65 & 2.50 (2 x s,
3H), 2.25-1.92 (m, 4H), 1.59 & 1.57 (2 x s, 3H), 1.51 & 1.42 (2 x d, J = 1.1 Hz, 3H,
H), 1.25 & 1.19 (2 x s, 9H). 13C NMR (two rotamers present) δ: 172.8, 153.1, 141.6,
141.4, 128.6, 127.2 & 126.9, 80.1, 66.0, 51.9, 47.2 & 47.0, 38.6 & 38.2, 29.6 & 29.4,
28.7, 24.7 & 24.5, 23.8 & 23.6, 22.1 & 21.8. HRMS (ESI) calculated for C19H29N2O3
[M+H]+: 347.2335. Found: 347.2325.

The reaction was then conducted using (S)-N-methylbenzyl amine, following the
method previously described, forming the (R,S) and (S,S) diastereoisomers 22c and
22d.

(R,S) Diastereoisomer (22c): Colourless oil, (0.13 g, 19 %). [α]D: -8.2 (c = 0.55 in
MeOH). Analytical data is identical to that of the (S,R) diastereoisomer. HRMS (ESI)
calculated for C19H29N2O3 [M+H]+: 347.2335. Found: 347.2320.
(S,S) Diastereoisomer (22d): Colourless oil, (0.24 g, 35 %). [α]D: -24 (c = 0.7 in
MeOH). Analytical data is identical to that of the (R,R) diastereoisomer. HRMS (ESI)
calculated for C19H29N2O3 [M+H]+: 347.2335. Found: 347.2335.

2-Methyl-pyrrolidine-2-carboxylic acid methyl-(1-phenyl-ethyl)-amide (17a-d).
To a solution of 22(a-d) (0.145 g, 0.42 mmol) in DCM (0.3 ml) was added TFA (0.3
ml, 1.28 mmol), and it was stirred at ambient temperature for 16 hr. It was then
concentrated in vacuo, dissolved in H2O (40 ml), and the pH was adjusted to ~ 8 by
adding Et3N dropwise, at 0 oC. It was then extracted with DCM (3 x 20 ml), dried
over MgSO4, and concentrated in vacuo yielding an oil, which was purified on silica
gel using 5% MeOH:DCM.

23

(S,R) Diastereoisomer (17a): Colourless oil, (0.09 g, 88 %).
Rf: 0.6 (10 % MeOH: DCM). [α]D: + 18 (c = 1 in MeOH). IR, (Thin film)/cm-1:
3276, 2974, 1676. 1H NMR (two rotamers present) δ: 7.40-7.22 (m, 5H), 6.04 & 5.35
(2 x q, J = 7.0 Hz, 1H), 3.47-3.41 & 3.11-3.02 (2 x m, 2H), 2.74 (s, 3H), 2.30-1.95
(m, 4H), 1.75 & 1.70 (2 x s, 3H), 1.53 (d, J = 7.1 Hz, 3H).
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C NMR (two rotamers

present) δ: 172.8, 139.4, 129.0, 127.7 & 127.1, 68.3, 52.7, 45.6, 36.2, 30.4, 25.6, 23.9,
15.2. HRMS (ESI) calculated for C15H23N2O [M+H]+: 247.1810. Found: 247.1821.
(R,R) Diastereoisomer (17b): Colourless oil, (0.092 g, 89 %). Rf: 0.5 (10 % MeOH:
DCM). [α]D: + 25 (c = 1 in MeOH). IR, (Thin film)/cm-1: 3270, 2976, 1674. 1H
NMR (two rotamers present) δ: 7.36-7.23 (m, 5H), 6.06 & 5.56 (2 x q, J = 7.1 Hz,
1H), 3.26-3.20 & 3.01-2.92 (2 x m, 2H), 2.76 & 2.70 (2 x s, 3H), 2.17-1.83 (m, 4H),
1.59 (s, 3H), 1.51 (d, J = 7.0 Hz, 3H).
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C NMR (two rotamers present) δ: 174.7,

130.1, 128.6, 127.4 & 126.3, 66.9, 52.3, 46.2 , 36.6, 30.4, 26.0, 25.6, 15.2. HRMS
(ESI) calculated for C15H23N2O [M+H]+: 247.1810. Found: 247.1810.
(R,S) Diastereoisomer (17c): Colourless oil, (0.095 g, 92 %). [α]D: - 18 (c = 1 in
MeOH). Analytical data is identical to that of the (S,R) diastereoisomer. HRMS (ESI)
calculated for C15H23N2O [M+H]+: 247.1810. Found: 247.1821.
(S,S) Diastereoisomer (17d): Colourless oil, (0.095 g, 92 %). [α]D: - 26 (c = 1 in
MeOH). Analytical data is identical to that of the (R,R) diastereoisomer. HRMS (ESI)
calculated for C15H23N2O [M+H]+: 247.1810. Found: 247.1808.

2-Methyl-2-(1-phenyl-ethylcarbamoyl)-pyrrolidine-1-carboxylic acid tert-butyl
ester (22e-h).
To a stirred solution of 21 (0.50 g, 2.18 mmol) in dry DMF (10 ml) was added DIPEA
(0.75 ml, 4.36 mmol), followed by (R)-1-phenylethylamine (0.29 ml, 2.18 mmol)
dropwise. After 5 min stirring, the solution was cooled to 0 oC, and a solution of
HATU (0.84 g, 2.2 mmol) in dry DMF (10 ml) was added slowly. After 10 min at this
temperature, the solution was allowed to warm to ambient temperature and stirring
was continued for 3 hr. The solution was diluted with EtOAc (200 ml), and then
washed successively with 10 % HCl (3 x 10 ml), saturated aqueous sodium carbonate
24

solution (3 x 10 ml), H2O (3 x 10 ml) and brine solution (3 x 10 ml), and then dried
over MgSO4. The solution was concentrated in vacuo yielding a colourless oil (0.70
g), which was purified by column chromatography on silica gel in 10 % ethyl acetate:
petroleum ether.

(S,R) Diastereoisomer (22e): White solid, (0.38 g, 52 %). Rf: 0.70 (40 % ethyl
acetate: petroleum ether). M.p.: 129-132 oC. [α]D: - 18.6 (c = 0.7 in MeOH). IR,
(KBr)/cm-1: 3305, 2976, 1682, 1671. 1H NMR δ: 7.82 (s(br), 1H), 7.32-7.26 (m, 5H),
5.07 (s(br), 1H), 3.52-3.25 (m(br), 2H), 2.68-2.62 (m(br), 1H), 2.19-2.15 (m(br), 1H),
1.67-1.70 (m(br), 2H), 1.57 (m(br), 6H), 1.47 (s, 9H).
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C NMR δ: 173.7, 152.5,

129.2, 128.2, 127.1, 48.2, 28.5, 22.4, 18.4. HRMS (ESI) calculated for C19H29N2O3
[M+H]+: 333.2178. Found: 333.2174.

(R,R) Diastereoisomer (22f): Colourless oil, (0.30 g, 42 %). Rf: 0.60 (40 % ethyl
acetate: petroleum ether). [α]D: + 3.8 (c = 0.5 in MeOH). IR, (Thin film)/cm-1: 3308,
2972, 1684, 1672. 1H NMR δ: 7.78 (s(br), 1H) 7.33-7.28 (m, 5H), 5.08 (m(br), 1H),
3.53 (m(br), 2H), 2.66 (m(br), 1H), 2.28 (m(br), 1H), 1.79 (m(br), 2H), 1.58 (m(br),
6H), 1.46 (s(br), 9H, I).
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C NMR (ppm) δ: 173.7, 127.4, 126.3, 125.9, 48.6, 28.2,

23.4, 22.6. HRMS (ESI) calculated for C19H29N2O3 [M+H]+: 333.2178. Found:
333.2193.

The reaction was then conducted using (S)-(1)-phenylethyl amine, following the
method previously described, forming the (R,S) and (S,S) diastereoisomers.
(R,S) Diastereoisomer (22g): White solid, (0.38 g, 52 %). M.p.: 128-131 oC. [α]D:
+ 18.5 (c = 0.7 in MeOH). Other analytical data is identical to that of 22e. HRMS
(ESI) calculated for C19H29N2O3 [M+H]+: 333.2178. Found: 333.2192.
(S,S) Diastereoisomer (22h): Colourless oil, (0.30 g, 42 %). [α]D: - 4.0 (c = 0.5 in
MeOH). Other analytical data is identical to that of 22f. HRMS (ESI) calculated for
C19H29N2O3 [M+H]+: 333.2178. Found: 333.2180.

2-Methyl-pyrrolidine-2-carboxylic acid (1-phenyl-ethyl)-amide (17)
25

To a solution of 22(e-h) (0.2 g, 0.602 mmol) in DCM (0.4 ml) was added TFA (0.4
ml, 1.7 mmol), and then stirred at ambient temperature for 16 hr. The solution was
then concentrated in vacuo, dissolved in H2O (40 ml), and the pH adjusted to ~ 8 by
adding Et3N dropwise, at 0 oC. It was then extracted with DCM (3 x 20 ml), dried
over MgSO4, and concentrated in vacuo yielding an oil, which was purified on silica
gel in 5% MeOH:DCM.

(S,R) Diastereoisomer (17e): Yellow solid, (0.14 g, 96 %). Rf: 0.2 (5 % MeOH:
DCM). M.p.: 100-103 oC. [α]D: + 30.5 (c = 1 in MeOH). IR, (KBr)/cm-1: 3414, 3270,
2974, 1673. 1H NMR δ: 8.25 (br. s, 1H), 7.35-7.21 (m, 5H), 5.04 (q, J = 7.1 Hz, 1H),
3.08-3.03 & 2.83-2.76 (2 x m, 2H), 2.23-2.17 (m, 1H), 1.71-1.53 (m, 3H), 1.46 (d, J =
6.9 Hz, 3H), 1.43 (s, 3H). 13C NMR δ: 178.0, 144.0, 128.5, 126.9, 125.9, 66.6, 48.1,
47.4, 37.6, 26.5, 25.9, 22.3. HRMS (ESI) calculated for C14H21N2O [M+H]+:
233.1654. Found: 233.1649.

(R,R) Diastereoisomer (17f): Yellow oil, (0.13 g, 93 %). Rf: 0.2 (5 % MeOH:
DCM). [α]D20: + 95 (c = 1 in MeOH). IR, (Thin film)/cm-1: 3416, 3272, 2976, 1674.
1

H NMR δ: 8.12 (s (br), 1H), 7.36-7.22 (m, 5H), 5.03 (q, J = 6.9 Hz, 1H), 3.21-3.12

& 2.96-2.88 (2 x m, 2H), 2.32-2.26 (m, 1H), 1.84-1.63 (m, 3H), 1.47 (d, J = 7.0 Hz,
3H), 1.44 (s, 3H).
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C NMR δ: 175.3, 146.4, 128.6, 127.2, 126.0, 67.1, 48.5, 46.8,

37.4, 28.5, 26.1, 22.8. HRMS (ESI) calculated for C14H21N2O [M+H]+: 233.1654.
Found: 233.1660.
(R,S) Diastereoisomer (17g): Yellow solid, (0.133 g, 95 %). M.p.: 106-109 oC. [α]D:
- 30.5 (c = 1 in MeOH).

Other analytical data is identical to that of 17e

diastereoisomer. HRMS (ESI) calculated for C14H21N2O [M+H]+: 233.1654. Found:
233.1652.

(S,S) Diastereoisomer (17h): Yellow oil, (0.133 g, 95 %). Rf: 0.2 (5 % MeOH:
DCM). [α]D: - 81 (c = 1 %, l = 2 dm, MeOH). Other analytical data is identical to that
of 17f diastereoisomer. HRMS (ESI) calculated for C14H21N2O [M+H]+: 233.1654.
Found: 233.1647.

Pyrrolidine-1,2-dicarboxylic acid 1-tert-butyl ester (23)
26

A suspension of N-Boc-L-proline methyl ester7c (1.25 g, 5.45 mmol) and NaOH
(0.216 g, 5.4 mmol) in MeOH/H2O (1:1, 20 ml) was heated at reflux temperature for 5
hr. The solvent was removed in vacuo, and the residue was dissolved partitioned
between diethyl ether and H2O (1:1, 20 ml). The aqueous phase was then washed with
diethyl ether (3 x 10 ml), acidified to pH ~ 3 using 1N HCl, and extracted with diethyl
ether (20 ml). The ether layer was then dried over MgSO4 and concentrated in vacuo
giving the product as a white solid (1.15 g, 98 %). It was used without further
purification. Rf: 0.1 (20 % ethyl acetate: petroleum ether). M.p.: 133-136 oC. IR,
(KBr)/cm-1: 2976, 1739, 1639, 1431. 1H NMR (two rotamers present) δ: 4.36-4.25
(m, 1H), 3.52-3.33 (m, 2H), 2.40-2.27 (m, 1H), 2.18-1.88 (m, 3H), 1.50 & 1.43 (2 x s,
9H). 13C NMR (ppm) δ: 177.1, 156.7, 79.8, 67.2, 47.2, 28.3, 28.1, 23.7.
2S-(1’R-Phenyl-ethylcarbamoyl)-pyrrolidine-1-carboxylic acid tert-butyl ester
(24a)
To a stirred solution of 23 (0.32 g, 1.50 mmol) in dry DCM (5 ml) was added (R)-1phenylethylamine (0.17 ml, 1.50 mmol) dropwise, followed by DMAP (0.183 g, 1.50
mmol). After 5 min stirring, the solution was cooled to 0 oC, and a solution of EDC
(0.316 g, 1.65 mmol) in dry DCM (5 ml) was added slowly. After 5 min at this
temperature, the solution was allowed to warm to ambient temperature and stirring
was continued for 16 hr. The solvent was removed in vacuo and the resulting solid
was dissolved in EtOAc (30 ml). It was washed successively with H2O (3 x 10 ml), 5
% HCl solution (3 x 10 ml), saturated aqueous sodium carbonate solution (3 x 10 ml),
brine (3 x 10 ml) and then dried over MgSO4. It was concentrated in vacuo yielding a
colorless oil (0.46 g), which was purified by column chromatography on silica gel in
20 % ethyl acetate: petroleum ether giving a white solid (0.44 g, 90 %). Rf: 0.3 (40 %
ethyl acetate: petroleum ether). M.p.: 81-84 oC. [α]D: + 38.5 (c = 1 in MeOH). IR,
(KBr)/cm-1: 3304, 2976, 1688, 1676. 1H NMR δ: 7.51 (s (br), 1H), 7.31-7.22 (m,
5H), 5.10 (s (br), 1H), 4.32 (s (br), 1H), 3.34 (s (br), 2H), 2.41 (s (br), 1H), 2.13 (s
(br), 1H), 1.85 (s (br), 4H), 1.45 (s, 9H).
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C NMR δ: 171.3, 155.1, 143.0, 128.6,

125.9, 47.1, 28.4. Some signals missing due to line broadening.

HRMS (ESI)

+

calculated for C18H27N2O3 [M+H] : 319.2022. Found: 319.2015.
2S-(1’S-Phenyl-ethylcarbamoyl)-pyrrolidine-1-carboxylic acid tert-butyl ester
(24b)
27

Prepared from 21 (0.32 g, 1.50 mmol) in a similar manner to 24a using (R)-1phenylethylamine. The crude product was purified by column chromatography on
silica gel in 20 % ethyl acetate: petroleum ether giving a white solid (0.44 g, 90 %).
Rf: 0.2 (40 % ethyl acetate: petroleum ether). M.p.: 98-101 oC. [α]D: - 130 (c = 1 in
MeOH). IR, (KBr)/cm-1: 3305, 2977, 1688, 1675. 1H NMR δ: 7.51 (s (br), 1H),
7.31-7.25 (m, 5H), 5.10 (s (br), 1H), 4.33 & 4.25 (2 x m, 1H), 3.35 (s (br), 2H), 2.41
(s (br), 1H), 2.12 (s (br), 1H), 1.85 (s (br), 5H), 1.46 (s, 9H).

13

C NMR δ: 171.6,

154.1, 143.2, 130.7, 128.6, 127.1, 80.5, 48.6, 28.1. HRMS (ESI) calculated for
C18H27N2O3 [M+H]+: 319.2022. Found: 319.2007.

2S-Pyrrolidine-2-carboxylic acid (1’R -phenyl-ethyl)-amide (18a)
To a solution of 24a (1.0 g, 3.14 mmol) in DCM (2 ml) was added TFA (2 ml, 17
mmol), and the solution was stirred at ambient temperature for 16 hr. It was then
concentrated in vacuo, dissolved in H2O (40 ml), and the pH adjusted to ~ 8 by adding
Et3N dropwise, at 0 oC. The product was then extracted with DCM (3 x 20 ml), dried
over MgSO4, and concentrated in vacuo yielding an oil, which was purified on silica
gel in 5% MeOH:DCM, giving the product as a yellow oil (0.62 g, 91 %). Rf: 0.5 (10
% MeOH: DCM). [α]D: + 21.5 (c = 1 in MeOH). IR, (Thin film)/cm-1: 3412, 3263,
2976, 1672. 1H NMR δ: 7.97 (s (br), 1H), 7.35-7.21 (m, 5H), 5.09-5.04 (m, 1H),
3.91-3.86 (m, 1H), 3.08-2.92 (m, 2H), 2.22-2.10 (m, 1H), 1.93-1.87 (m, 1H), 1.771.70 (m, 2H), 1.47 (d, 3H, J = 7.1 Hz).

13

C NMR δ: 173.6, 144.8, 128.6, 127.3,

126.0, 60.3, 49.2, 48.6, 30.6, 25.9, 21.5. HRMS (ESI) calculated for C13H19N2O
[M+H]+: 219.1497. Found: 219.1498.

2S-Pyrrolidine-2-carboxylic acid (1’S-phenyl-ethyl)-amide (18b)
Prepared from 24b (1.0 g, 3.14 mmol) in a similar manner to 18a to give 18b as a
yellow oil (0.64 g, 94 %). Rf: 0.4 (10 % MeOH: DCM). [α]D: - 48 (c = 1 in MeOH).
IR, (Thin film)/cm-1: 3414, 3260, 2977, 1670. 1H NMR δ: 8.08 (s (br), 1H), 7.347.20 (m, 5H), 5.30-5.01 (m, 1H), 4.43-4.41 (m, 1H), 3.49-3.10 (m, 2H), 2.38-2.34 (m,
1H), 1.94-1.86 (m, 3H), 1.48 (d, 3H, J = 7.2 Hz).

13

C NMR δ: 168.8, 143.1, 128.7,

127.4, 125.8, 59.5, 50.3, 46.4, 30.2, 24.8, 22.0. HRMS (ESI) calculated for
C13H19N2O [M+H]+: 219.1497. Found: 219.1497.
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2S-[Methyl-(1’R-phenyl-ethyl)-carbamoyl]-pyrrolidine-1-carboxylic

acid

tert-

butyl ester (25a)
To a solution of 24a (0.5 g, 1.57 mmol) in dry THF (5 ml) at -20 oC, was added a
1.0M solution of LiHMDS in THF (1.62 ml, 1.62 mmol) slowly, while keeping the
temperature below -15 oC. The solution was stirred for 30 min., under nitrogen, at this
temperature. Methyl iodide (0.30 ml, 3.93 mmol) was added slowly at -20 oC. The
solution was stirred while allowing it to warm to ambient temperature. After 18 hr the
solution was quenched with 1N HCl (20 ml), and the majority (80%) of the solvent
was removed in vacuo. The remaining suspension was diluted with diethyl ether (40
ml) and the organic phase was separated, washed with 1N HCl solution (3 x 10 ml),
saturated aqueous sodium chloride solution (3 x 10 ml), then dried over MgSO4, and
concentrated in vacuo. The crude product was purified by column chromatography on
silica gel in 30 % ethyl acetate: petroleum ether giving a yellow oil (0.50 g, 92 %). Rf:
0.3 (20 % ethyl acetate: petroleum ether). [α]D: +48.3 (c = 0.6 in MeOH). IR, (Thin
film)/cm-1: 2978, 1697, 1654. 1H NMR (two rotamers present) δ: 7.34-7.20 (m, 5H),
6.15-6.05 (m, 1H), 5.02 & 4.60 (2 x m, 1H), 3.70-3.35 (m, 2H), 2.82 & 2.70 (2 x s,
3H), 2.12-2.08 (m, 2H), 1.95-1.88 (m, 2H), 1.65 (s, 3H), 1.48 & 1.35 (2 x s, 9H).

13

C

NMR (two rotamers present) δ: 173.6, 153.4, 140.3, 128.8, 128.2, 127.0, 56.7, 50.5,
46.8, 30.6, 29.5, 28.5, 24.4, 15.6. HRMS (ESI) calculated for C19H29N2O3 [M+H]+:
333.2178. Found: 333.2171.

2S-[Methyl-(1’S-phenyl-ethyl)-carbamoyl]-pyrrolidine-1-carboxylic

acid

tert-

butyl ester (25b)
Prepared from 24b (0.5 g, 1.57 mmol) in a similar manner to 25a. The crude product
was purified by column chromatography on silica gel in 30 % ethyl acetate: petroleum
ether giving a yellow oil (0.52 g, 98 %). Rf: 0.2 (20 % ethyl acetate: petroleum ether).
[α]D: -102.3 (c = 0.85 in MeOH). IR, (Thin film)/cm-1: 2978, 1696, 1653. 1H NMR
(two rotamers present) δ: 7.34-7.21 (m, 5H), 6.04 (m, 1H), 4.67 & 4.55 (2 x m, 1H),
3.68-3.45 (m, 2H), 2.73 & 2.68 (2 x s, 3H), 2.08-2.02 (m, 2H), 1.89-1.85 (m, 2H),
1.58 (s, 3H), 1.48 & 1.45 (2 x s, 9H).

13

C NMR (two rotamers present) δ: 172.9,

151.3, 141.6, 128.5, 128.4, 127.2, 57.8, 50.6, 47.1, 29.2, 28.9, 28.5, 23.5, 15.2. HRMS
(ESI) calculated for C19H29N2O3 [M+H]+: 333.2178. Found: 333.2166.
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2S-Pyrrolidine-2-carboxylic acid methyl-(1’R-phenyl-ethyl)-amide (18c)
To a solution of 25a (0.3 g, 0.903 mmol) in DCM (0.6 ml) was added TFA (0.6 ml,
2.6 mmol), and the solution was stirred at ambient temperature for 16 hr. It was
concentrated in vacuo, dissolved in H2O (40 ml), and the pH was adjusted to ~ 8 by
adding Et3N dropwise, at 0 oC. The product was then extracted with DCM (3 x 20
ml), dried over MgSO4, and concentrated in vacuo yielding an oil, which was purified
on silica gel in 5% MeOH:DCM, giving the product as a yellow oil (0.18 g, 86 %). Rf:
0.6 (10 % MeOH: DCM). [α]D: + 41 (c = 1 in MeOH). IR, (Thin film)/cm-1: 3438,
2979, 1697, 1655. 1H NMR (two rotamers present) δ: 8.10 (d (br), 1H), 7.40-7.22 (m,
5H), 5.92 (q, 1H, J = 7.1 Hz), 5.30 & 4.74, 3.98 & 3.69 (4 x m, 1H), 3.49-3.39 &
3.18-2.90 (2 x m, 2H), 2.76 & 2.71 (2 x s, 3H), 2.51-1.58 (m, 4H), 1.50 & 1.47 (2 x d,
3H, J = 7.1 Hz). 13C NMR (two rotamers present) δ: 172.1 & 169.3, 142.8 & 138.5,
129.1, 128.6, 127.1, 60.3 & 58.1, 52.3 & 48.4, 47.1 & 46.6, 30.6 & 29.7, 25.8 & 25.6,
22.2, 15.6. HRMS (ESI) calculated for C14H21N2O [M+H]+: 233.1654. Found:
233.1661.

2S-Pyrrolidine-2-carboxylic acid methyl-(1’S-phenyl-ethyl)-amide (18d)
Prepared from 25b (0.3 g, 0.903 mmol) in a similar manner to 18c to give an oil,
which was purified on silica gel in 5% MeOH:DCM, giving the product as a yellow
solid (0.19 g, 88 %). Rf: 0.5 (10 % MeOH:DCM). M.p.: 172-175 oC. [α]D: - 120 (c =
1 in MeOH). IR, (KBr)/cm-1: 3436, 2980, 1698, 1650. 1H NMR (two rotamers
present) δ: 7.39-7.21 (m, 5H), 5.93 (q, 1H, J = 7.1 Hz,), 5.05 & 4.84, (2 x m, 1H),
3.56-3.51 & 3.46-2.38 (2 x m, 2H), 2.69 (s, 3H), 2.54-2.47 (m, 1H), 2.21-2.14 (m,
1H), 2.08-2.00 (m, 1H), 1.88-1.82 (m, 1H), 1.55 (d, 3H, J = 7.2 Hz). 13C NMR (two
rotamers present) δ: 169.3, 138.8, 129.3, 128.8, 127.2, 58.0, 52.4, 46.7, 29.7, 29.1,
25.3, 15.2. HRMS (ESI) calculated for C14H21N2O [M+H]+: 233.1654. Found:
233.1655.
General procedure for the Michael Addition reaction of aldehydes and  nitrostyrene.
To a solution of the β-nitrostyrene (0.15 g, 1 mmol) in dry DCM (1 ml) was added the
relevant catalyst (0.05 mmol), followed by the aldehyde (1.5 mmol). The reaction was
stirred at ambient temperature for 48 or 72 hours, under a nitrogen atmosphere. It was
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then diluted with chloroform (5 ml) and treated with 1N HCl (4 ml), while stirring
vigorously. The aqueous layer was extracted with chloroform and the combined
organic layers were dried over MgSO4 and concentrated in vacuo. The crude product
was purified by column chromatography on silica gel with 5% EtOAc: petroleum
ether. For example, 2-propyl-4-nitro-3-phenylbutyraldehyde (16): Rf: 0.6 (20% ethyl
acetate: petroleum ether). Analytical data was as reported in the literature.12 HPLC
data: Chiralcel OD-H column; flow 1.6 ml/min using 90/10 hexane/2-propanol, syn tr
= 6.4 min (S,R) and 8.9 min (R,S), anti tr = 7.6 min and 13.0 min.

X-Ray data
The data were collected at 150(2)K on a Bruker Apex II CCD diffractometer. The
structures were solved by direct methods13,14 and refined on F2 using all the
reflections.14 All the non-hydrogen atoms were refined using anisotropic atomic
displacement parameters and hydrogen atoms bonded to carbon were inserted at
calculated positions using a riding model. The H atoms bonded to nitrogen or oxygen
were located from difference maps and refined with thermal parameters riding on the
carrier atoms.

Crystal data for 11b. C20H28N2O3, M = 344.44. orthorhombic, a = 6.5297(9), b =
16.557(2), c = 17.425(3) Å, U = 1883.9(5) Å3, T = 150(2) K, space group P212121, Z =
4, 14987 reflections measured, 1930 independent reflections (Rint = 0.0534). The final
wR(F2) was 0.0949 (all data) and R1 was 0.0374 for I>2s(I). CCDC No. 687387.

Crystal data for 17b.TsOH. C22H30N2O4S, M = 418.54. orthorhombic, a = 7.8627(11),
b = 12.6431(18), c = 21.679(3) Å, U = 2155.1(5) Å3, T = 150(2) K, space group
P212121, Z = 4, 19139 reflections measured, 4406 independent reflections (Rint =
0.0571) which were used in all calculations.13 The final wR(F2) was 0.0812 (all data)
and R1 was 0.0397 for I>2s(I). CCDC No. 749092.

Crystal data for 22g. C19H28N2O3, M = 332.43. orthorhombic, a = 9.9790(9), b =
16.6480(15), c = 23.276(2) Å, U = 3866.9(6) Å3, T = 150(2) K, space group P212121,
Z = 8, (two independent molecules in the asymmetric unit), 34133 reflections
measured, 4427 independent reflections (Rint = 0.0801). The final wR(F2) was 0.0820
(all data) and R1 was 0.0400 for I>2s(I). CCDC No. 749093.
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